The company discontinued developing emugrobart after two studies showed the drug didn’t achieve intended outcomes.

Chugai Pharmaceutical Co. fell 7.3%, the largest intraday decline since August 2025, after the company said it had ended the ...

A thoughtfully balanced, multi-protein, meat-first recipe with bioavailable nutrients, puppy-appropriate super grains ...

The big pharma company will no longer progress emugrobart to late-stage trials in FSHD and SMA due to a lack of efficacy.

Original story from Technion-Israel Institute of Technology (Haifa, Israel). An implantable tissue flap containing muscle and ...

The ACSM released new resistance training guidelines to improve muscle strength, size, and performance. medical News today ...

Intestinal microorganisms can affect human muscle strength. This is the conclusion reached by the researchers in a paper ...

In an on-going overhaul of NASA's Artemis program, agency officials say it will take seven years to build a sophisticated ...

When stem cells are injected into thick tissues, they often clump together and die from lack of oxygen or nutrients, making ...

Parent Project Muscular Dystrophy (PPMD), the leading U.S. non-profit driving Duchenne and Becker muscular dystrophy care, research, and advocacy efforts, and Secretome Therapeutics (Secretome) are ...

In the case of a child with Down Syndrome, if therapy is started at a very early age, it has the potential to enhance the ...

We have identified a macrophage population "Mrep" that plays an essential role in muscle repair. However, in Fibrodysplasia ...